🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Alaunos Therapeutics Inc (TCRT)

NASDAQ
Currency in USD
2.080
+0.062(+2.97%)
Closed
After Hours
2.040-0.040(-1.923%)
TCRT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.0212.120
52 wk Range
1.95032.850
Key Statistics
Edit
Prev. Close
2.08
Open
2.03
Day's Range
2.021-2.12
52 wk Range
1.95-32.85
Volume
7.2K
Average Vol. (3m)
25.13K
1-Year Change
-75.67%
Book Value / Share
1.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TCRT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Alaunos Therapeutics Inc Company Profile

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.

Compare TCRT to Peers and Sector

Metrics to compare
TCRT
Peers
Sector
Relationship
P/E Ratio
−0.3x−1.5x−0.6x
PEG Ratio
0.000.030.00
Price / Book
1.2x2.1x2.6x
Price / LTM Sales
475.8x24.6x3.2x
Upside (Analyst Target)
-427.3%45.4%
Fair Value Upside
Unlock21.3%7.7%Unlock

People Also Watch

26.88
AS
+4.35%
4.170
RBBN
+5.30%
125.04
VRT
-0.64%
3.020
ATYR
-4.73%
60.80
ATLC
-1.90%

FAQ

What Is the Alaunos Therapeutics (TCRT) Stock Price Today?

The Alaunos Therapeutics stock price today is 2.08

What Stock Exchange Does Alaunos Therapeutics Trade On?

Alaunos Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Alaunos Therapeutics?

The stock symbol for Alaunos Therapeutics is "TCRT."

What Is the Alaunos Therapeutics Market Cap?

As of today, Alaunos Therapeutics market cap is 3.25M.

What is Alaunos Therapeutics Earnings Per Share?

The Alaunos Therapeutics EPS is -7.36.

From a Technical Analysis Perspective, Is TCRT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.